Navigation Links
Feeding hormone ghrelin modulates ability of rewarding food to evoke dopamine release
Date:7/11/2011

07/07/11, Clearwater Beach, FL. New research findings to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, finds that ghrelin, a natural gut hormone that stimulates feeding, also modulates the ability of tasty food and food-related cues to alter dopamine levels within the striatum, a critical component of the brain's reward system.

Scientists measured dopamine in 'real-time' while rats ate sugar, a highly rewarding food. Administering ghrelin to rats while they ate sugar increased peak dopamine "spikes" within the striatum, whereas administering a drug that blocks ghrelin's actions significantly reduced dopamine levels during sugar intake. Study author Dr. Mitch Roitman (University of Illinois at Chicago) says, "The modulation of brain dopamine reward signals by a gut hormone that regulates appetite strongly supports this interaction as a way to direct the organism's behavior towards further intake, perhaps by making food more rewarding. The results shed light on how peripheral body signals in general can shape brain-directed behavior."


'/>"/>

Contact: Jamie Price
jamie@spltrak.com
312-238-9068
Society for the Study of Ingestive Behavior
Source:Eurekalert

Page: 1

Related biology news :

1. Study suggests prolonged bottle feeding increases the risk of obesity
2. Breastfeeding tied to stronger maternal response to babys cry
3. WALTHAM Centre for Pet Nutrition sheds new light on feeding behavior of domestic cats
4. Montrealers are feeding fish Prozac
5. Oil giant plans new platform near feeding ground of critically endangered whale
6. New public health goals tackle obstacles to breastfeeding success
7. Even the sickest babies benefit from breast-feeding
8. Black mothers cite lack of desire as top reasons for not breastfeeding
9. Biologists identify genes regulating sleeping and feeding
10. Fossil-fuel use and feeding world cause greatest environmental impacts: UNEP panel
11. About 94 percent of breastfeeding mothers do not follow a proper diet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: